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Abstract: Infection with Toxoplasma gondii results in retinochoroiditis in 6% to 20% of 
immunocompetent individuals. The outcome of infection is the result of a set of interactions 
involving host genetic background, environmental, and social factors, and the genetic background 
of the parasite, all of which can be further modiﬁ  ed by additional infections or even reinfection. 
Genes that encode several components of the immune system exhibit polymorphisms in their 
regulatory and coding regions that affect level and type of expression in response to stimuli, 
directing the immune response into different pathways. These variant alleles have been associated 
with susceptibility to immune-mediated diseases and with severity of pathology. We have 
investigated polymorphisms in several of these genes, identiﬁ  ed as candidates for progression to 
retinochoroiditis caused by toxoplasmosis, namely chemokine (C-C motif) receptor 5 (CCR5), 
toll-like receptor-2 (TLR2), and TLR4. Furthermore, because interleukin-12 (IL-12) has been 
shown to be fundamental both in mice and in man to control a protective response against 
T. gondii, molecules that have a key function in IL-12 production will be emphasized in this 
review, in addition to discussing the importance of the genetic background of the parasite in 
the establishment of ocular disease.
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Toxoplasma gondii, an obligate intracellular protozoan parasite, infects close to a 
billion people worldwide (Tenter et al 2000) and is an important agent of animal and 
human disease worldwide (Dubey and Beattie 1988; Wong and Remington 1993; 
Petersen and Dubey 2001).
Toxoplasmosis in humans and other mammals is acquired by oral ingestion of 
either tissue cysts in raw or undercooked meat from chronically infected intermediate 
hosts or by ingestion of oocysts shed by cats by way of fecal contamination of food or 
water (Frenkel 1988, 1990). Once ingested, the cyst wall is digested within the lumen 
of the small intestine. The acute phase of infection is characterized by wide-spread 
dissemination of rapidly dividing tachyzoites that invade virtually all cell types.
During the inﬂ  ammatory process, soluble mediators and cellular components work 
together in a systematic manner in the attempt to contain and to eliminate the agents 
causing physical distress. The nature and portal of entry of the foreign substance and, 
to some degree, the nature and circumstances of a particular individual inﬂ  uence the 
way in which the inﬂ  ammatory process is initiated.
Pathogens can initiate inﬂ  ammation by a number of distinct and characteristic 
mechanisms, including activation of the plasma protease systems by interaction 
with degradation products of the pathogens and by secretion of toxins that can 
activate the inﬂ  ammatory response directly. Injured cells themselves can release 
degradation products that initiate one or more of the plasma protease cascades and 
augment expression of proinﬂ  ammatory cytokines that promote the inﬂ  ammatory Clinical Ophthalmology 2008:2(4) 838
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process. The physiological changes in inﬂ  ammation are 
crucial to maintain the health and integrity of an organism, 
however, the inﬂ  ammatory process can result in massive 
tissue destruction when poorly controlled.
During invasion of T. gondii, the host cell is essentially 
passive and no change is detected in membrane rufﬂ  ing, 
actin cytoskeleton, or phosphorylation of host cell proteins 
(Furtado et al 1992; Manger et al 1998; Ortega-Barria 
and Boothroyd 1999; Jacquet et al 2001). The invasion is 
an active parasite-mediated process, initiated by contact 
between the apex of T. gondii and the host cell surface, 
involving many host receptors (proteoglycans like heparin 
and heparin-sulphate, β-integrins) and parasite ligands such 
as surface antigens (SAG), surface antigen-related sequences 
(SRS), microneme proteins (MIC), and laminin (Yap and 
Sher 1999).
Intestinal epithelial cells probably are the ﬁ  rst cells 
infected by T. gondii. Chemokines released by these cells 
play a critical role in the initiation and modulation of 
immune response to various pathogens (Perez de Lema 
et al 2001). They are responsible for the chemoattraction 
of polymorphonuclear neutrophils (PMNs), dendritic cells 
(DC), macrophages (MØ), and lymphocytes (Mackay 2001). 
T. gondii infects and can be disseminated by these cells to 
other organs throughout the host, especially to, muscle and 
central nervous system.
The disease in animal models
The T. gondii mouse infection model, because of its simplicity 
and robust responses it generates, has proven a powerful tool 
for studying host-microbe interactions. Because of that, 
most of the data published on immune responses and genes 
implicated in susceptibility derive from studies employing 
inbred mouse strains. Infection of mice leads to lifelong per-
sistence of the parasite. Outcome is variable, depending on 
the interaction of many factors like inoculum size (Liesenfeld 
1999), virulence of the organism (Su et al 2002), life cycle 
stage of the parasite (Johnson 1984; McLeod et al 1989a; 
Suzuki et al 1989a, 1993), genetic background (Williams et al 
1978; McLeod et al 1989b; Suzuki et al 1996; Lu et al 2005), 
gender (Roberts et al 1995), and immunological status. All 
these factors seem to affect the course of infection in human 
beings and in animal models of toxoplasmosis.
Murine susceptibility to T. gondii or resistance to mortal-
ity following acute oral infection is under multigenic control 
by the host (Williams et al 1978; McLeod et al 1989a; John-
son et al 2002). In C57BL/6 mice, genes both within and 
outside of the major histocompatibility complex (MHC) are 
involved in impaired intracerebral immune response (Brown 
and McLeod 1990; Deckert-Schluter et al 1994).
The ability of mice to survive T. gondii infection is 
dependent on strong T cell-mediated immunity. Both CD4+ T 
helper (Th) 1 cells and CD8+ cytolytic T lymphocytes are 
vital in providing protective immunity and long-term survival 
during chronic infection, as determined by in vivo depletion 
studies and adoptive transfer of CD4+ and CD8+ T cell lines 
and clones (Suzuki et al 1988; Gazzinelli et al 1991, 1992; 
Parker et al 1991; Kasper et al 1992; Buzoni-Gatel et al 
1997). If the host becomes immunosuppressed, chronic infec-
tion can be reactivated, leading to toxoplasmic encephalitis, 
which is often fatal if not treated (Suzuki 2002).
The protective competence of these cell types is due to 
their ability to produce interferon (IFN)-γ, a pro-inﬂ  ammatory 
cytokine that has become well known as the major mediator 
of resistance to T. gondii (Suzuki et al 1988). Mice that do not 
express IFN-γ (IFN-γ knockout mice) are unable to survive 
the acute phase of infection (Scharton-Kersten et al 1996). 
Antibody-mediated depletion of this cytokine during chronic 
infection demonstrates that continued IFN-γ production is 
necessary for long-term survival (Gazzinelli et al 1992). 
However, pathologic consequences due to overproduction of 
cytokines and excessive activation of the immune system are 
observed in IL-10 knockout (IL-10 KO) mice infected with 
T. gondii (Gazzinelli et al 1996) or wild type mice infected 
with highly virulent strains (Mordue et al 2001).
The activation of murine macrophages (MØ) by IFN-γ in 
the presence of additional signals, such as lipopolysaccharide 
(LPS) or tumor necrosis factor-α (TNF-α), is necessary to 
trigger the cytotoxic activity of MØ against T. gondii (Sibley 
et al 1993). IFN-γ exerts its antimicrobial activity through 
induction of speciﬁ  c effector molecules, including reactive 
nitrogen intermediates that interfere with key metabolic 
enzymes (Khan et al 1997; Scharton-Kersten et al 1997; 
Roberts et al 2000), indoleamine 2,3-dioxygenase (IDO) 
that induces tryptophan degradation thereby interfering with 
viability of the parasite (MacKenzie et al 1999; Fujigaki 
et al 2002; Silva et al 2002), and a family of GTP-binding 
proteins. IFN-γ-inducible GTP-binding proteins IGTP and 
LRP-47 are required for the mice to survive acute T. gondii 
infection, while nitric oxide-dependent protection may be 
more important during chronic infection (Taylor et al 2000; 
Collazo et al 2001).
The intraocular inﬂ  ammatory response to the parasite is 
also mediated primarily by the CD4+ T- and CD8+ T-cell 
responses. CD8+ T cells recognize and destroy parasite-
infected cells in an MHC class I restricted manner. However, Clinical Ophthalmology 2008:2(4) 839
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as part of the local immune privilege, cells in the eye 
express low levels of MHC class I while infected mice 
usually show increased expression (Lyons et al 2001). 
This would, in turn, permit the precise targeting of 
T. gondii-infected cells by CD8+ cytolytic T lymphocytes 
and unlike other killing mechanisms that rely on soluble 
mediators, would limit collateral damage to uninfected 
cells. Indeed, depletion of the CD8+ cell subset resulted in 
increased lesion formation and cyst burden in an acquired 
disease model of infection (Gazzinelli et al 1994a), and 
a severe necrosis accompanied by higher ocular parasite 
burdens, in CD8-deﬁ  cient mice immunized and challenged 
by a intraocular inoculum (Lu et al 2004). B cells may also 
contribute by limiting tachyzoite proliferation in the eyes 
(Lu et al 2004).
Programmed cell death is an important protective strategy 
used in immune-privileged organs. Fas is expressed on a 
variety of immune and nonimmune cells, whilst FasL is 
evident on T cells as well as in immune-privileged tissues. 
Ligation of these two surface molecules results in apop-
tosis of the Fas-expressing cell. In this way, the eye can 
prevent the damage caused by inﬁ  ltrating lymphocytes and 
activated T cells can induce apoptosis in infected cells. 
T. gondii induces increased Fas and FasL expression on the 
cells of mouse retina. When intracamerally inoculated with 
tachyzoites of one virulent strain, Fas- and FasL-defective 
mice exhibit greater inﬂ  ammatory scores and a more severe 
histopathology than similarly infected wild-type mice, added 
to a reduced ability to limit parasite proliferation early in 
infection (Hu et al 1999, 2001). However, when intraperi-
toneally inoculated with a less virulent strain, the same mice 
showed no difference in the degree of ocular inﬂ  ammation 
and apoptosis. The higher level of IFN-γ and NO apparent 
early in these mice must have provided an alternative 
means to control parasitemia in the absence of Fas or FasL 
expression (Shen et al 2001).
In the immunosuppressed environment of the eye with 
high levels of TGF-β antigen-presenting cells can produce 
IL-10 when activated, which would stimulate the expansion 
of a regulatory T cell subset able to counteract the Th1 type 
pro-inﬂ  ammatory responses and thus maintain the immune 
privilege. Nevertheless, the ocular pathogenesis in C57BL/6 
mice is more severe than that of BALB/c and CBA/J mice and 
the serum levels of IFN-γ and TNF-α in C57BL/6 mice are 
signiﬁ  cantly higher than those in BALB/c and CBA/J mice 
following ocular infection with a virulent strain of T. gondii 
(Lu et al 2005). There are higher levels of IFN-γ mRNA 
expression in the retinas of C57BL/6 mice than in those of 
BALB/c mice infected with T. gondii (Norose et al 2003). 
Furthermore, a decline in IFN-γ production in CD4-KO mice 
protects mice from mortality due to an exacerbated immune 
response (Casciotti et al 2002). IFN-γ has been shown to 
regulate the T. gondii load and inter-conversion between the 
bradyzoite and tachyzoite stages of T. gondii in the murine 
eye (Norose et al 2003). Therefore, IFN-γ mediates immuno-
pathology and contributes to early death following T. gondii 
infection (Liesenfeld et al 1996).
Toxoplasmosis
Some recent studies support the idea that T. gondii is a 
master manipulator of host immune responses. The parasite 
simultaneously triggers the secretion of protective cytokines 
(IFN-γ and IL-12) and paradoxically suppresses the same 
type of response (Denkers et al 2004; Gaddi and Yap 2007). 
This dual capacity of the parasite could actually be beneﬁ  cial 
and allow the establishment of a stable host–parasite interac-
tion. Failure to successfully synchronize these responses has 
negative consequences for both. Antimicrobial protection is 
ensured by the coordinated action of the innate and adaptative 
immune systems. Molecular communication between the 
host innate immune system and the intracellular protozoan 
T. gondii is fast emerging as a dramatic example of these key 
principles in action.
In the immunocompetent host the acute infection is usu-
ally asymptomatic or causes a inﬂ  uenza-like syndrome, and 
rarely leads to severe symptoms such as interstitial pneu-
monia, pericardial effusions, myositis, myocarditis, and 
neurological disorders (retinochoroiditis, Guillain-Barré 
syndrome, mental confusion) (Bossi and Bricaire 2004). 
Encephalitis is most commonly seen in immunocompro-
mised individuals whereas uveitis is the most common 
lesion appearing in immunocompetent individuals (Hill 
and Dubey 2002). The infection incites a quasiefﬁ  cient 
immune response, which controls parasitemia but allows 
tissue cysts to form in the brain, eyes, and muscles, lead-
ing to lifelong persistence of the parasite and variable 
medical outcome.
Dissemination of T. gondii in immunocompromised hosts, 
such as AIDS patients with very low CD4 counts, patients 
under immunosuppression to prevent or treat transplant 
rejection, and fetuses, is common, and often represents a reac-
tivation of an earlier infection, rather than a newly acquired 
one. In these individuals the parasite can, besides encephalitis 
and retinochoroiditis, cause carditis, pneumonia, and men-
ingitis, amongst other manifestations (Hill and Dubey 2002; 
Mele et al 2002; Montoya and Liesenfeld 2004).Clinical Ophthalmology 2008:2(4) 840
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Ocular lesions may result from congenital or after 
birth-acquired infections. The lesion is often necrotic, 
destroying the architecture of the neural retina and some-
times involving the choroid (retinochoroiditis). Typical 
ﬁ  ndings of toxoplasmic retinochoroiditis include white 
focal lesions with an intense overlaying and vitreal 
inﬂ  ammatory reaction. Toxoplasmic retinochoroiditis is 
the most common lesion caused by infection with this 
protozoan and it may occur either immediately or long 
after the initial infection (Silveira et al 1988; Couvreur 
and Thulliez 1996; Montoya and Remington 1996) or 
reactivation (Bosch-Driessen et al 2002).
Recurrent lesions are usually identiﬁ  ed at the borders 
of the retinochoroidal scars, are typically found in clusters, 
and have been attributed to the rupture of tissue cysts within 
these old lesions or eventually coming from other tissues due 
to activation of memory immune cells. It is thought that the 
satellite lesions occurring both in the brain and the eye are 
caused by rupture of local cysts (Holland 2003, 2004), but the 
origin of active infections in remote tissues has been credited 
to either clinically unapparent tissue cysts or to re-infection 
(Hill and Dubey 2002). In this last case, it is conceivable that 
the immune response by memory cells might be triggered by 
circulating parasites or even by other infections, through the 
activation of IFN-γ and other inﬂ  ammatory mediators.
Many questions about the disease still remain that 
confound ophthalmologists (Vallochi et al 2002; Holland 
2003, 2004). The response to antibiotic therapy alone or 
in combination with corticosteroids varies widely among 
patients (Stanford et al 2003). Clinical presentation also 
varies, with some patients presenting only one episode of 
mild inﬂ  ammation whereas others have multiple recurrences 
of severe uveitis leading to loss of eyesight. The immune 
response against retinal antigens does not explain the exten-
sive damage to the eye in patients with ocular toxoplasmo-
sis. Furthermore, we have presented data suggesting that a 
controlled autoimmune response may develop after infection 
with T. gondii in some patients and, in addition, may help to 
prevent the parasite from spreading through the retina thus 
associated with a milder disease (Vallochi et al 2005a).
Familial ocular toxoplasmosis is found in southern Brazil, 
where the incidence of ocular toxoplasmosis is higher than 
in most regions of the globe, and accounts for 70% to 90% 
of all uveitis cases seen in rural areas. A household survey in 
the endemic area showed 17,7% (186/1,042) of the popula-
tion had toxoplasmic scars in the retina (Silveira et al 1988; 
Glasner et al 1992), a ﬁ  nding that cannot be explained by 
congenital infection alone (Holland 2003, 2004). The same 
population was reassessed 7 and 11 years later and showed 
that seroconversion was more frequent in individuals under 
17 years of age or above 50 years of age, with a risk of 10% 
of ocular involvement (Silveira et al 2001; Silveira 2002). 
Finally, acquired infection causing late necrotizing retino-
choroiditis is seen not only in Brazil (Nussenblatt and Belfort 
1994), but also in Europe (Brezin and Cisneros 1999) and in 
the USA (Montoya and Remington 1996).
Analysis of systemic cellular response to T. gondii antigen 
in 136 subjects with a diagnosis of ocular toxoplasmosis, 
no ocular disease or no infection by T. gondii suggested 
that resistance to the development of ocular toxoplasmo-
sis has been associated with the ability to mount a lasting 
T-helper (Th) 1-type response (IL-2 and IFN-γ production) 
to the parasite antigens. On the other hand, susceptibility 
has also been associated with an inﬂ  ammatory response, 
mostly mediated by cytokines (IL-1 and TNF-α) possibly 
produced by activated macrophages (MØ), which may them-
selves take part in the pathological features of the disease 
(Yamamoto et al 2000).
A recent study performed in France is in opposition to our 
study. Analyzing the induction of CD25 expression, no sig-
niﬁ  cant difference was observed in immune response among 
16 individuals with a diagnosis of congenital, acquired, or 
undetermined ocular toxoplasmosis or between patients 
with active or inactive ocular lesions. Furthermore, higher 
levels of IFN-γ were detected in stimulated blood cultures 
from infected patients than in those from controls, with no 
difference between patients with asymptomatic or ocular 
toxoplasmosis (Fatoohi et al 2006).
TNF-α also plays an important role in murine resistance 
to acute and chronic toxoplasmosis (Chang et al 1990; 
Johnson 1992; Langermans et al 1992). However, high 
levels of this cytokine produced during any lethal infection 
can potentially contribute to harmful cerebral and hepatic 
effects (Black et al 1989; Beaman et al 1992; Marshall 
et al 1999). Furthermore, TNF-α may aid the intracerebral 
dissemination of T. gondii in mice (Grau et al 1992) and 
may be increased in toxoplasmic retinochoroidal in humans 
(Yamamoto et al 2000).
We have shown that individuals with ocular toxoplasmosis 
from congenital infection have a diminished immune 
response towards T. gondii antigens when compared with 
individuals with ocular disease due to acquired infection 
(Yamamoto et al 2000). Interestingly, unlike mice, the 
diminished response is not caused by a superantigen 
(Vallochi et al 2001). This means that, despite the similarity 
at macroscopic and histopathologic level, the lesions seen on Clinical Ophthalmology 2008:2(4) 841
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ocular toxoplasmosis may be generated by different mecha-
nisms, therefore explaining the wide range of responses to 
available therapy.
Toxoplasma genotype and pathology
Variation of clinical presentation and severity of disease in 
susceptible individuals has been attributed to several factors, 
including host genetic heterogeneity and parasite genotype 
(Boothroyd and Grigg 2002). We have typed T. gondii strains 
in Brazil (Vallochi et al 2005b) and our ﬁ  ndings reveal that 
the highly clonal population structure of T. gondii seen in 
North America and Europe does not predominate in South 
America (Khan et al 2006). Identiﬁ  cation of the direct players 
in host–pathogen interactions during the initial infection and 
chronic phases of the disease is perhaps the best hope for 
better clinical treatment in this region.
Population studies analyzing more than 50 different 
genetic markers have identiﬁ  ed a limited number of T. gondii 
genotypes in nature, despite the presence of a sexual phase 
in the life cycle, a wide geographical distribution and a 
broad range of intermediate hosts. Phylogenetic analysis 
detects 2 main groups in T. gondii population. From a 
practical point of view, 3 main lineages (type I, type II, 
and type III) that despite sharing about 98% genetic iden-
tity differ in virulence and epidemiological pattern of 
occurrence (Darde 2004; Switaj et al 2005), are usually 
considered. For most groups, allelic polymorphism is low 
(2 to 4 alleles) (Darde et al 1992; Howe and Sibley 1995; 
Ajzenberg et al 2002), indicating that they descend recently 
from two closely-related parents that underwent a small 
number of genetic recombination events. Less than 1% of 
the previously studied strains contain unique genotypes and 
high divergence of DNA sequence, and have therefore been 
considered ‘exotic’ or ‘atypical’ strains (Su et al 2003). 
However, it was demonstrated that sexual recombination 
combining polymorphisms in two of these distinct and 
competing clonal lines, can be a powerful force driving 
the natural evolution of virulence in this highly successful 
pathogen (Grigg et al 2001).
The apparently low genetic diversity in T. gondii may 
have been underestimated because most parasite strains 
in previous studies were collected from human patients 
and domestic animals in North America and Europe. The 
choice largely employed by researchers is using the SAG2 
locus for rapid typing since it is capable of distinguishing 
all three alleles from a single locus (Howe et al 1997). This 
method is also widely used in other genes where the popula-
tion structure has not been studied so extensively, therefore 
genetic diversity is under-represented. Several studies have 
examined the distribution of genotypes in chickens from 
countries such as Egypt, Argentina, India, and Brazil (Dubey 
et al 2002, 2003a, 2003b, 2003c; Sreekumar et al 2003; 
Lehmann et al 2004), but the genetic studies were limited 
by the use of only one marker (SAG2) (except [Sreekumar 
et al 2003; Lehmann et al 2004]), and because chickens in 
farms are indicators of strain prevalence in a domestic or 
peridomestic environment. Strains isolated from humans and 
animals (rabbit, mouse, goat, chickens, and dogs) in Minas 
Gerais, Brazil were analyzed by polymerase chain reaction-
restriction fragment length polymorphism (PCR–RFLP) at 
eight independent loci and all strains carried recombinant 
genotypes, with typical types I, II, or III in almost all loci 
assessed (de Melo Ferreira et al 2006).
We also have identified type I T. gondii strains 
by PCR-based typing at the SAG2 locus in retinochoroidal 
specimens from Brazil (Vallochi et al 2005b). When ana-
lyzed by multilocus PCR-RFLP, our recent ﬁ  ndings reveal 
that the highly clonal population structure of T. gondii 
seen in North America and Europe does not predominate 
in South America (Khan et al 2006). Consistent with this 
observation, T. gondii strains isolated from French Guiana 
patients are also highly diversiﬁ  ed and not characteristic of 
a clonal organism as seen in North America strains (Ajzen-
berg et al 2004).
In the Brazilian strains, genotyping showed no cases of 
mixed infection (two alleles at a given locus). Unfortunately, 
the true extent of sequence divergence is not captured 
by multilocus RFLP and microsatellite analysis tends 
to overestimate genetic divergence. The UPRT-1 intron 
sequence was compared, and all except one strain from Brazil 
proved to have multiple additional polymorphisms not seen 
in the clonal lineages. This analysis suggested the presence 
of more than one predominant haplotype in Brazil along with 
less common unique genotypes (Khan et al 2006).
It has been suggested previously that such divergent 
strains are more ancient in origin than the recently derived 
clonal lineages and that T. gondii expansion is linked to 
enhanced oral transmission between intermediate hosts, a 
trait not shared by other closely related parasites (Su et al 
2003). Despite of high serologic prevalence and level of 
recurrent ocular disease in Erechim, Brazil (Glasner et al 
1992), it is premature to say that sexual reproduction plays a 
central role in the population structure of T. gondii, since there 
were no cases of mixed infection. Given that the samples 
are from two small outbreaks and one of them due to food 
borne. It is likewise early to describe the epidemiology of Clinical Ophthalmology 2008:2(4) 842
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toxoplasmosis in Brazil, since it is a country of continential 
size, boasting tropical and subtropical areas.
Recent studies in mice have identified some genes 
responsible for the strain-speciﬁ  c differences in virulence 
(Taylor et al 2006; Saeij et al 2007), where type I strains 
are more virulent than types II and III. As virulence is a 
multigenic trait, crossing the less virulent type II and type 
III strains generates some F1 progeny in which the virulence 
is greatly enhanced. The use of QTL mapping in such prog-
eny identiﬁ  ed a total of ﬁ  ve virulence loci, including one 
on chromosome VIIa, which was found to correspond to 
ROP18, and one on chromosome VIIb, which corresponded 
to a gene encoding another rhoptry kinase, ROP16 (Saeij 
et al 2007). ROP18 encodes the ROP18 protein, which is 
a functional serine kinase and is secreted into host cells 
(Taylor et al 2006). ROP16 is a key modulator of the host 
response and the three clonal lineages differ in their level 
of activation of the STAT signaling pathway. As this is the 
pathway to the crucial cytokine interleukin 12, ROP16 is 
involved in this effect (Saeij et al 2007). It seems that these 
eukaryotic pathogens can secrete protein kinases into host 
cells to subvert host-cell signaling pathways and that this 
explains many of the differences in virulence among the 
three dominant clonal lineages.
Our ﬁ  ndings reveal that the genetic makeup of T. gondii 
is more complex than previously recognized and are in 
agreement that unique or divergent genotypes may contribute 
to different clinical outcomes of toxoplasmosis in different 
localities. Further strain comparisons based on a wider set 
of sequence based markers will be necessary to deﬁ  ne the 
global population structure of T. gondii and to resolve the 
relationships between major strain types seen in different 
geographic regions.
Host genotype and the immune 
response to T. gondii
A wide array of studies has further demonstrated 
differences in genotype and allele frequencies of cytokine 
gene polymorphisms depending on ethnicity and race 
(Golovleva et al 1997; Cox et al 2001; Uboldi de Capei 
et al 2003). Cytokines and chemokines and Toll-like 
receptors play a key role in the regulation of the type and 
magnitude of immune response, and the polymorphic 
nature of these genes may confer further ﬂ  exibility to the 
immune response (Schroder and Schumann 2005). We 
have analyzed some of the genes involved in the response 
against T. gondii infection, whose functions are detailed 
in the following pages.
Toll-like receptors
Toll-like receptors (TLRs) have been recently deﬁ  ned as 
important transmembrane proteins that can confer a cer-
tain degree of speciﬁ  city to the cells of the innate immune 
compartment. TLRs, also referred to as pattern recognition 
receptors (PRRs), have been implicated in recognition of 
every known category of pathogen that causes human disease 
and whose signaling through the common adaptor mol-
ecule myeloid differentiation primary-response protein 88 
(MyD88) is essential in proinﬂ  ammatory cytokine responses 
to many microbial pathogens.
TLRs can recognize traces of microbial components and 
orchestrate an early defense, largely dependent on the activa-
tion of nuclear factor-kappaB (NF-κB), which will lead to 
the production of proinﬂ  ammatory cytokines and triggering 
of microbiostatic/microbicidal effector mechanisms (Iwasaki 
and Medzhitov 2004). While major advances have been 
made in the assignment of individual TLRs to deﬁ  ned roles 
in bacterial infections (Takeda et al 2003), such identiﬁ  cation 
has only recently begun to emerge in protozoan parasites 
(Gazzinelli et al 2004).
Mice that are deficient in the TLR adaptor protein 
MyD88 were found to have a pronounced decrease in IL-
12 production by peritoneal macrophages, neutrophils, and 
splenic DC in response to soluble tachyzoite antigen (STAg) 
stimulation in vivo and in vitro being highly susceptible to 
the acute infection with low doses of the infective stage of 
T. gondii (Scanga et al 2002). At this lower parasite dose, 
neither TLR2 nor TLR4 were important for mouse resistance 
to infection with T. gondii. In addition, DC from TLR2- or 
TLR4-KO mice developed normal IL-12 responses to STAg 
(Scanga et al 2002) just as PMNs from TLR2-KO animals 
did (Del Rio et al 2004). TLR2-KO mice produce sufﬁ  cient 
IL-12 to mediate partial protection that is nonetheless not 
enough to provide complete resistance to high dose infec-
tion, as compared to the wild type or TLR4-KO mice (Mun 
et al 2003). Hence, TLR2 might be involved in the early 
activation of the innate immune system during infection with 
T. gondii to be partially involved in the parasite recognition 
and MyD88 activation during early stages of infection with 
T. gondii. It seems that the defect seen in TLR2-KO mice is 
due to inefﬁ  cient activation of microbicidal functions, with 
diminished nitric-oxide production by macrophages (Mun 
et al 2003).
Alternatively, MyD88-dependent neutrophil production of 
CCL2 (monocyte chemoattractant protein 1), but not IL-12, is 
dependent upon TLR2 signaling and defective CCL2 release 
could confer partial susceptibility to infection (Del Rio et al Clinical Ophthalmology 2008:2(4) 843
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2004). Of note, neutrophil IL-12 production is not dependent 
upon parasite cyclophilin-18 (C-18), a T. gondii protein shown 
to trigger DC IL-12 through CCR5 ligation (Aliberti et al 
2003). Thus, T. gondii possesses multiple molecules triggering 
distinct MyD88-dependent signaling cascades, and as these 
pathways are independently regulated, they may lead to dis-
tinct proﬁ  les of cytokine production (Del Rio et al 2004).
MyD88 signaling occurs also through IL-1R or IL-18R, 
but ICE-KO mice (lacking functional IL-1 and IL-18) 
exhibit no increased susceptibility to infection suggesting 
that signaling through IL-1R and IL-18R is not essential for 
responses against T. gondii infection. Importantly, TLR1-, 
TLR2-, TLR4-, TLR6-, and TLR9-KO mice exhibited similar 
resistance to infection compared with wild-type mice sug-
gesting that these receptors are not independently essential 
for control of T. gondii infection (Hitziger et al 2005).
A recent study from our laboratory indicates that there is 
no association between polymorphisms in TLR2 (Arg677Trp 
and Arg763Gln) and TLR4 (Asp299Gly) and ocular toxoplas-
mosis in Brazilian patients (unpublished observations), a ﬁ  nd-
ing in keeping with the observations in the murine model.
On the other hand, of the whole family of TLRs, two 
distinct TLR have been implicated in the recognition of 
protein ligands. TLR5 has been shown to be triggered by 
bacterial flagellin while TLR11 signaling is stimulated 
by protease sensitive molecules in uropathogenic bacteria 
(Hayashi et al 2001; Zhang et al 2004). TLR11 was impli-
cated in resistance to T. gondii when an additional ligand in 
the parasite, T. gondii proﬁ  lin (PTG), that apparently triggers 
high DC IL-12 production by a MyD88 dependent but CCR5 
independent pathway, was discovered (Yarovinsky et al 
2005). Interestingly, while DC IL-12 production appeared to 
be almost totally impaired in TLR11-KO mice infected with 
T. gondii, these animals, unlike either MyD88 or IL-12-KO 
mice (Reis e Sousa et al 1997) retained partial resistance to 
challenge and survived the acute phase of the infection, most 
likely due to a residual IFN-γ response (Yarovinsky et al 
2005). It is important to note however, that human TLR11 
is nonfunctional because of the presence of a stop codon in 
the gene (Zhang et al 2004). At present it is not clear whether 
TLR11 recognition of T. gondii is of importance in limiting 
infection in other mammalian species or whether humans 
utilize alternative pattern recognition receptors in the innate 
response to T. gondii.
Interleukin-12
Immunity to T. gondii involves acute inﬂ  ammatory responses 
and antigen-speciﬁ  c adaptive immunity (Denkers and Gazzi-
nelli 1998; Cai et al 2000). Central to host resistance is the 
generation of IFN-γ by innate-type natural killer (NK) cells 
and adaptive CD4 and CD8 T lymphocytes (Suzuki et al 
1988, 1989b). IL-12 has been identiﬁ  ed as critical for driv-
ing prompt IFN-γ production and proper differentiation of 
Th1 lymphocytes during the immune response to T. gondii 
(Gazzinelli et al 1994b; Yap et al 2000).
IL-12 is produced by PMNs, DC, B cells and other 
antigen-presenting cells (APCs). PMNs store cytokines 
in pre-formed pools namely IL-12, IL-6, MIP-2 in mouse 
neutrophils in the absence of infection (Terebuh et al 1992; 
Bliss et al 2000; Matzer et al 2001), and IL-4 in PMN from 
healthy human donors (Brandt et al 2000). T. gondii induces 
secretion of IL-12 directly and rapidly by both human and 
mouse neutrophils, DCs as well as MØ (Gazzinelli et al 
1993; Reis e Sousa et al 1997; Bliss et al 1999a, 1999b; 
Denkers et al 2003; Robben et al 2004). Release of IL-12 
does not require IFN-γ priming since responses are intact 
in gene-targeted mice lacking this cytokine. On the other 
hand, recombinant TNF-α alone stimulates CCL2 and CCL4 
production by PMN, and therefore, the ability of T. gondii to 
trigger TNF-α may provide an important positive feedback 
loop for release of neutrophil CCL2 and CCL4, important 
chemokines which recruit macrophages and other cells 
to infected tissue. T. gondii also induces up regulation of 
RANTES (CCL5), MIP-3α (CCL20) and macrophage 
chemoattractant protein-1 (MCP-1; CCL2) gene transcription 
by PMN (Bennouna et al 2003), which recruited to the site 
of infection by chemokines such as IL-8 and MCP-1, are 
themselves equipped to immediately release cytokines and 
chemokines that contribute further to cell recruitment and 
activation.
IL-12 is composed of two subunits, IL-12 p40 and 
IL-12 p35. In the absence of the IL-12 p40 gene or the 
IL-12-receptor-associated signal transducers Tyk2 and 
STAT-4, IFN-γ production is severely impaired resulting 
in enhanced susceptibility to acute T. gondii infection (Yap 
and Sher 1999; Cai et al 2000; Shaw et al 2003). In contrast, 
the IL-12-related cytokine, IL-23, which is composed of 
the shared IL-12 p40 subunit and a unique p19 subunit is 
not required or essential for mouse immunity to T. gondii 
infection (Lieberman et al 2004). Thus, IL-12 p40 production 
by DC and via a MyD88-dependent recognition mechanism 
is critical and perhaps sufﬁ  cient for initiating IFN-γ-medi-
ated immunity to T. gondii (Reis e Sousa et al 1997; Scanga 
et al 2002). Related cytokines such as IL-18 and IL-23 may 
instead play a pathogenic role (Mordue et al 2001; Gaddi 
and Yap 2007).Clinical Ophthalmology 2008:2(4) 844
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Studies of differential production of IL-12 in BALB/c 
and DBA/2 mice suggest that strain-speciﬁ  c variation not 
encoded by MHC genes affects IL-12 production with a 
skewing of antigen-speciﬁ  c recall responses to either a Th1 or 
a Th2 direction (Gieni et al 1996). In humans, deletions 
of IL-12 p40 or IL-12 receptors lead to serious impairment 
of immunity against intracellular bacteria (Altare et al 1998; 
de Jong et al 1998). A complete genomic sequence analysis 
of the IL-12 gene encoding its p40 subunit (IL-12B) identi-
ﬁ  ed several intronic polymorphisms, a single-nucleotide 
polymorphism (SNP) at position +16974 (+16974 A/C) in 
the 3’-untranslated region (UTR) of IL-12B (Hall et al 2000; 
Huang et al 2000) and a promoter polymorphism (IL-12Bpro) 
(Morahan et al 2002).
Association between genotype (+16974 A/C) and 
IL-12p40 production by stimulated PBMC was observed 
and depend on the stimuli used. There is a signiﬁ  cantly 
decreased IL-12 p40 secretion for the following order of 
genotypes: AA   CA   CC, after stimulation of PBMC 
with C3-binding glycoprotein (C3bgp) in contrast to 
lipopolysaccharide, phytohaemagglutinin and pokeweed 
mitogen (Stanilova and Miteva 2005). Furthermore, poly-
morphisms in the IL12B 3’UTR gene have been show to 
inﬂ  uence the secretion of IL-12 and susceptibility to Type 
1 diabetes (Windsor et al 2004), and the promoter polymor-
phism may inﬂ  uence the outcome of malaria infection in at 
least one African population (Morahan et al 2002).
CCR5
Although low-level IFN-γ production occurs in the absence 
of IL-12 signaling, optimal induction is strictly IL-12-
dependent (Cai et al 2000). Therefore, much effort has been 
dedicated to disclose the mechanism(s) by which T. gondii 
tachyzoites elicit the production of IL-12 during the initial 
stages of infection.
The best deﬁ  ned mechanism by which T. gondii induces 
the production of IL-12 is through the parasite-derived 
cyclophilin-18, which signals murine DCs to produce IL-
12 via the chemokine receptor CCR5 (Aliberti et al 2000; 
Aliberti et al 2003). The biological relevance of the unusual 
requirement for a chemokine receptor to participate in micro-
bial recognition by DCs is supported by the observation that 
IL-12 production is decreased during acute infections of 
CCR5-KO animals (Aliberti et al 2000), although defects 
in cell migration could also contribute to this susceptible 
phenotype. In theory, cell-surface CCR5 on DCs could 
deliver signals derived from stimulation with autologous 
chemokines that have been induced following microbial 
stimulation or could be directly triggered by pathogen 
derived ligands.
In humans, a mutant allele of the CCR5 gene, bearing 
a 32-bp deletion, results in reduced CCR5 cell surface 
expression (Blanpain et al 2000). However, we couldn’t 
observe association between the allele CCR5Δ32 and 
ocular toxoplasmosis in Brazilian patients (unpublished 
observations). Incidentally, we and others have found this 
variant to be quite rare in Brazilian population samples 
(unpublished results).
The IL-12 levels observed after stimulation of murine 
DCs with C-18 are much lower than those seen after stimula-
tion with whole-parasite lysate or with a pool of tachyzoite-
secreted proteins, indicating that pathways other than those 
initiated by CCR5 and C-18 might also be important for IL-12 
production by DCs (Aliberti et al 2003).
Conclusion
While the data summarized in this review demonstrate 
that the binomial IL-12 and IFN-γ production is critical to 
resistance to T. gondii infection in mice, and that an intricate 
mechanism involving simultaneous activation of different 
signaling pathways could be required for induction and 
control of IL-12 during acute infection with T. gondii, much 
remains to be learned about the mechanisms involved and 
their relevance to parasite and host interactions during natu-
ral infection in humans. We had discussed the importance 
of the genetic background of both the parasite and the host 
in the establishment of ocular disease and the major ques-
tions concerning the speciﬁ  c receptors and parasite ligands 
required for innate immunity response triggering and how 
these interactions result in resistance to T. gondii.
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